Skip to main content
Top
Published in: Irish Journal of Medical Science (1971 -) 2/2018

01-05-2018 | Letter to the Editor

The case for medicinal cannabis

Authors: Jane O’Doherty, Ray O’Connor

Published in: Irish Journal of Medical Science (1971 -) | Issue 2/2018

Login to get access

Excerpt

Sources from Ireland, America, Serbia, and worldwide agree that cannabis is the most popular and most commonly used illicit substance worldwide [13]. Internationally, there has been a gradual shift from prohibition to medicinal uses [4]. There have been many cases described in the literature of patients suffering from chronic conditions such as cancer, arthritis, Parkinson’s disease, multiple sclerosis, human immunodeficiency virus (HIV) infection, epilepsy, migraine, autoimmune disease, and psychiatric disorders self-medicating with cannabis for its therapeutic effects [57]. In addition, a systematic review and meta-analysis of 79 trials involving 6462 patients concluded that there was moderate quality evidence supporting the medicinal use of certain cannabinoids [8]. There was also low-quality evidence supporting the use of cannabinoids for nausea and vomiting due to chemotherapy, sleep disorders, and Tourette’s syndrome [8]. More recently, cannabidiol has been shown to reduce seizure frequency in Dravet syndrome [9]. Cannabis contains several active substances. One which leads to addiction and is regarded as most toxic is tetrahydrocannabinol (THC) [10]. However, other compounds in cannabis, such as cannabidiol, appear to have therapeutic effect but with little of the addictive psychotropic effects. …
Literature
2.
go back to reference Health Products Regulatory Authority (2017) Cannabis for medical use—a scientific review. Ireland Health Products Regulatory Authority (2017) Cannabis for medical use—a scientific review. Ireland
Metadata
Title
The case for medicinal cannabis
Authors
Jane O’Doherty
Ray O’Connor
Publication date
01-05-2018
Publisher
Springer London
Published in
Irish Journal of Medical Science (1971 -) / Issue 2/2018
Print ISSN: 0021-1265
Electronic ISSN: 1863-4362
DOI
https://doi.org/10.1007/s11845-018-1770-9

Other articles of this Issue 2/2018

Irish Journal of Medical Science (1971 -) 2/2018 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.